Latest filing published 20 May 2021 for Xenon Pharmaceuticals Inc., €5,394.
Insider track record
Michael M. Tarnow: trading record in brief
All filings by Michael M. Tarnow on record concern Xenon Pharmaceuticals Inc. Between 12 December 2016 and 18 May 2021, the trades on record add up to 20 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 20 May 2021 with an option exercise (€5,394) in Xenon Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Michael M. Tarnow
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,057 shares@ CA$3.874.7% of flowCommon SharesTSXSEDI:3748652
- 1,028 shares@ CA$3.672.2% of flowCommon SharesTSXSEDI:3748654
- 5,144 shares@ CA$3.6711.1% of flowCommon SharesTSXSEDI:3748656
- 10,288 shares@ CA$3.74Common SharesTSXSEDI:3619619
- 5,144 shares@ CA$3.74Common SharesTSXSEDI:3619613
- 5,144 shares@ CA$3.749.9% of flowCommon SharesTSXSEDI:3561965
- 2,057 shares@ CA$3.7413.3% of flowCommon SharesTSXSEDI:3454353
- 5,144 shares@ CA$3.7433.3% of flowCommon SharesTSXSEDI:3454338
- 2,057 shares@ CA$3.744.5% of flowCommon SharesTSXSEDI:3371209
- 5,000 sharesCommon SharesTSXSEDI:3287713
- 12,345 shares@ CA$3.7425.8% of flowCommon SharesTSXSEDI:3201119
- 1,028 shares@ CA$3.746.7% of flowCommon SharesTSXSEDI:3023826
- 7,201 sharesCommon SharesTSXSEDI:2949236
- 7,202 shares@ CA$3.7416.8% of flowCommon SharesTSXSEDI:2926414
- 7,201 shares@ CA$3.7416.8% of flowCommon SharesTSXSEDI:2926367
15 of 15 declarations
